Vapotherm has decided to implement a direct sales channel in order to provide better service and more closely work with clinicians to provide the best possible care to patients.
Vapotherm is the inventor of high flow therapy (small prong high flow nasal cannula). Supported by a group of strong experienced Venture Capitalists the company has grown and become stronger, including relocating to NH, rolling out a robust quality management system, expanding our field sales and clinical teams, and building in house manufacturing and service capabilities. Vapotherm intends to remain the leader in high flow therapy innovation and provide the highest level of customer support. We believe this change will allow us to be closer to the customer, and to provide our products with greater flexibility at lower costs.